Wiesje van der Flier, PhD, describes how best to deliver a diagnosis of Alzheimer’s disease in the early stages, including how to discuss diagnostic test results with the patient. She outlines the value of patient involvement in registries and enrollment in clinical trials post diagnosis, before this is discussed in relation to the patient case study. José Luis Molinuevo then concludes the symposium, highlighting the importance of an early diagnosis of Alzheimer’s disease.
Disclosure: All panelists received honoraria from Biogen for participation in this symposium.
Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.